BACKGROUND	We evaluated the steroid-sparing efficacy of MTX ( 17.5 mg weekly ) compared with AZA ( 2.5 mg/kg daily ) in subjects recently diagnosed with generalized MG by assessing their average monthly prednisone requirements .\